澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

MAYNE PHARMA GROUP LTD

2.450

-0.070-2.78%

成交量：32.68万

成交额：80.29万

市值：1.99亿

市盈率：-2.33

高：2.500

开：2.480

低：2.420

收：2.520

52周最高：7.310

52周最低：2.420

股本：8,124.58万

流通股本：6,699.72万

量比：0.64

换手率：0.49%

股息：- -

股息率：- -

每股收益(TTM):-1.051

每股收益(LYR):-1.186

净资产收益率：-20.58%

总资产收益率：-2.30%

市净率：0.56

市盈率(LYR):-2.07

数据加载中...

总览公司新闻资讯公告

Mayne制药集团——将继续推进产品组合规模化战略，可能包含股票回购计划

MAYNE PHARMA GROUP LTD上诉理由曝光，拟挑战法院对该公司2025财年息税折旧摊销前利润等事项的裁决

Mayne Pharma收到Cosette及其Bidco向新南威尔士州最高法院上诉庭提交的上诉通知

MAYNE PHARMA GROUP LTD - 扩建生产设施正式启用仪式在南澳大利亚萨尔斯堡举行

Mayne Pharma Group Ltd - 与Cosette未能达成任何可能推进计划的协议

Mayne Pharma Group Ltd - Mayne Pharma发布终止计划实施契约的意向通知

澳大利亚以国家利益为由阻止科赛特收购梅恩制药公司

澳大利亚财政部长：基于国家利益将阻止Cosette制药收购MAYNE PHARMA GROUP LTD的提议

澳大利亚收购委员会发布最终命令，包括MAYNE PHARMA GROUP LTD同意财政部长对Salisbury合理要求的条件

澳大利亚收购委员会：6月24日至9月8日，市场未获知Cosette在Salisbury地点的意向变更

澳大利亚收购委员会：Cosette在Salisbury的意图变化意味着对MAYNE的控制市场未能按一般方式推进

澳大利亚收购委员会临时命令限制Cosette在未经事先同意的情况下采取任何终止Sid的措施

澳大利亚收购委员会 - 在特定情况下，委员会认为维持现状所需的临时命令是必要的

澳大利亚收购委员会 - 临时命令修订MAYNE PHARMA GROUP LTD与Cosette Pharma之间的方案实施契约结束日期定义

Mayne Pharma Group Ltd - 外国投资审查委员会将Firb批准的法定截止日期延长至11月17日

Mayne Pharma - ASIC正式批准公司将2025年股东大会的召开时间从11月28日或之前延长至1月30日或之前

澳大利亚收购委员会 - Mayne寻求最终命令，包括Cosette同意将 FIRB 的决定法定截止日期延长至12月1日

澳大利亚收购委员会 - Mayne寻求临时命令，包括Cosette向委员会确认将与Firb会面

澳大利亚财政部长考虑阻止科赛特竞购后，梅因制药股价大跌

梅因制药股价下跌至38.6%，因澳大利亚财政部长考虑阻止收购要约

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/MYX.AU/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MYX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MYX.AU\",,,,,undefined,":{"symbol":"MYX.AU","market":"AU","secType":"STK","nameCN":"MAYNE PHARMA GROUP LTD","latestPrice":2.45,"timestamp":1772428320000,"preClose":2.52,"halted":0,"volume":326842,"delay":0,"changeRate":-0.027777777777777714,"nameEN":"MAYNE PHARMA GROUP LTD","floatShares":66997185,"shares":81245827,"eps":-1.051059,"marketStatus":"未开盘","change":-0.07,"latestTime":"03-02 16:12:00 AEDT","open":2.48,"high":2.5,"low":2.42,"amount":802890,"amplitude":0.031746,"askPrice":2.52,"askSize":2233,"bidPrice":2.43,"bidSize":2263,"shortable":3,"etf":0,"ttmEps":-1.051059,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":0,"beginTime":1772492400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":2.52,"openAndCloseTimeList":[[1772406000000,1772427600000]],"volumeRatio":0.644656,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MYX.AU\",,,,,undefined,":{"symbol":"MYX.AU","floatShares":66997185,"roa":"-2.30%","roe":"-20.58%","lyrEps":-1.185711,"volumeRatio":0.644656,"shares":81245827,"dividePrice":0,"high":2.5,"amplitude":0.031746,"preClose":2.52,"low":2.42,"week52Low":2.42,"pbRate":"0.56","psRate":"0.49","week52High":7.31,"institutionHeld":0,"latestPrice":2.45,"committee":0.006673,"eps":-1.051059,"divideRate":0,"volume":326842,"delay":0,"ttmEps":-1.051059,"open":2.48,"prevYearClose":3.11,"prevWeekClose":2.52,"prevMonthClose":2.52,"prevQuarterClose":3.11,"fiveDayClose":2.61,"twentyDayClose":2.69,"sixtyDayClose":3.41,"dividendPayoutRate":0.04569711225089115,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0.014818181818181815},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MYX.AU\",params:#limit:5,,,undefined,":[{"date":"2026-02-22","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771714800000,"name":null,"time":"","dateTimestamp":1771678800000,"actualEps":null},{"date":"2025-08-29","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756425600000,"name":null,"time":"","dateTimestamp":1756389600000,"actualEps":null},{"date":"2025-02-26","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"date":"2024-08-23","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724371200000,"name":null,"time":"","dateTimestamp":1724335200000,"actualEps":null},{"date":"2024-02-26","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1708902000000,"name":null,"time":"","dateTimestamp":1708866000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MYX.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2023-01-18","recordDate":"2023-01-19","paymentDate":"2023-01-27","value":0.038,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MYX.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1174229185","title":"Mayne制药集团——将继续推进产品组合规模化战略，可能包含股票回购计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1174229185","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174229185?lang=zh_cn&edition=fundamental","pubTime":"2026-02-23 06:38","pubTimestamp":1771799894,"startTime":"0","endTime":"0","summary":"Mayne制药集团宣布将持续推进其产品组合的规模化战略，并透露未来可能采取包括股票回购在内的多元化举措。这一战略方向旨在优化公司资本结构并提升股东价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7096","MYX.AU"],"gpt_icon":0},{"id":"1112976135","title":"MAYNE PHARMA GROUP LTD上诉理由曝光，拟挑战法院对该公司2025财年息税折旧摊销前利润等事项的裁决","url":"https://stock-news.laohu8.com/highlight/detail?id=1112976135","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112976135?lang=zh_cn&edition=fundamental","pubTime":"2026-01-15 12:57","pubTimestamp":1768453037,"startTime":"0","endTime":"0","summary":"MAYNE PHARMA GROUP LTD已提交上诉通知书，其中列明的上诉理由旨在对法院就该公司2025财年息税折旧摊销前利润及其他相关财务指标所作出的认定提出异议。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","MYX.AU","BK7096"],"gpt_icon":0},{"id":"1175178833","title":"Mayne Pharma收到Cosette及其Bidco向新南威尔士州最高法院上诉庭提交的上诉通知","url":"https://stock-news.laohu8.com/highlight/detail?id=1175178833","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175178833?lang=zh_cn&edition=fundamental","pubTime":"2026-01-15 12:56","pubTimestamp":1768453014,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group Ltd（ASX: MYX）近日宣布，已收到Cosette Pharmaceuticals及其关联收购实体（Bidco）向澳大利亚新南威尔士州最高法院上诉庭提交的上诉通知书。该上诉针对此前法院作出的相关裁决提出异议，标志着双方围绕商业纠纷的法律对抗进入新一轮司法程序。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYX.AU","BK7096","BK7508"],"gpt_icon":0},{"id":"1124731935","title":"MAYNE PHARMA GROUP LTD - 扩建生产设施正式启用仪式在南澳大利亚萨尔斯堡举行","url":"https://stock-news.laohu8.com/highlight/detail?id=1124731935","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124731935?lang=zh_cn&edition=fundamental","pubTime":"2025-12-16 10:43","pubTimestamp":1765852990,"startTime":"0","endTime":"0","summary":"MAYNE PHARMA GROUP LTD - 扩建生产设施正式启用仪式在南澳大利亚萨尔斯堡举行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYX.AU","BK7508","BK7096"],"gpt_icon":0},{"id":"1146047415","title":"Mayne Pharma Group Ltd - 与Cosette未能达成任何可能推进计划的协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1146047415","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146047415?lang=zh_cn&edition=fundamental","pubTime":"2025-12-03 14:40","pubTimestamp":1764744019,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group Ltd - 与Cosette未能达成任何可能推进计划的协议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","MYX.AU","BK7096"],"gpt_icon":0},{"id":"1129229249","title":"Mayne Pharma Group Ltd - Mayne Pharma发布终止计划实施契约的意向通知","url":"https://stock-news.laohu8.com/highlight/detail?id=1129229249","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129229249?lang=zh_cn&edition=fundamental","pubTime":"2025-12-03 14:39","pubTimestamp":1764743948,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group Ltd - Mayne Pharma发布终止计划实施契约的意向通知","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7096","MYX.AU"],"gpt_icon":0},{"id":"2585647341","title":"澳大利亚以国家利益为由阻止科赛特收购梅恩制药公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2585647341","media":"路透中文","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585647341?lang=zh_cn&edition=fundamental","pubTime":"2025-11-21 09:17","pubTimestamp":1763687820,"startTime":"0","endTime":"0","summary":"更新 1-澳大利亚以国家利益为由阻止科赛特收购梅恩制药公司全文更新，提供声明中的更多细节和背景情况Renju Jose/Christine Chen路透悉尼11月21日 - 澳大利亚周五阻止了美国制药商Cosette Pharmaceuticals对Mayne Pharma MYX.AX提出的6.72亿澳元 的收购要约，称该收购不符合国家利益。\"这是为了保护澳大利亚的国家利益、重要医疗供应链的安全、当地就业岗位和当地社区而采取的必要行动\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251121:nL4S3WX04N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7096","MYX.AU"],"gpt_icon":0},{"id":"1101874220","title":"澳大利亚财政部长：基于国家利益将阻止Cosette制药收购MAYNE PHARMA GROUP LTD的提议","url":"https://stock-news.laohu8.com/highlight/detail?id=1101874220","media":"美股速递","labels":["policyRegulatory","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101874220?lang=zh_cn&edition=fundamental","pubTime":"2025-11-21 07:46","pubTimestamp":1763682370,"startTime":"0","endTime":"0","summary":"澳大利亚财政部长：基于国家利益将阻止Cosette制药收购MAYNE PHARMA GROUP LTD的提议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYX.AU","BK7508","BK7096"],"gpt_icon":0},{"id":"1104662603","title":"澳大利亚收购委员会发布最终命令，包括MAYNE PHARMA GROUP LTD同意财政部长对Salisbury合理要求的条件","url":"https://stock-news.laohu8.com/highlight/detail?id=1104662603","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104662603?lang=zh_cn&edition=fundamental","pubTime":"2025-11-19 16:04","pubTimestamp":1763539459,"startTime":"0","endTime":"0","summary":"澳大利亚收购委员会发布最终命令，包括MAYNE PHARMA GROUP LTD同意财政部长对Salisbury合理要求的条件。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYX.AU","BK7096","BK7508"],"gpt_icon":0},{"id":"1149255883","title":"澳大利亚收购委员会：6月24日至9月8日，市场未获知Cosette在Salisbury地点的意向变更","url":"https://stock-news.laohu8.com/highlight/detail?id=1149255883","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149255883?lang=zh_cn&edition=fundamental","pubTime":"2025-11-19 16:04","pubTimestamp":1763539459,"startTime":"0","endTime":"0","summary":"澳大利亚收购委员会：6月24日至9月8日，市场未获知Cosette在Salisbury地点的意向变更","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYX.AU","BK7508","BK7096"],"gpt_icon":0},{"id":"1170023886","title":"澳大利亚收购委员会：Cosette在Salisbury的意图变化意味着对MAYNE的控制市场未能按一般方式推进","url":"https://stock-news.laohu8.com/highlight/detail?id=1170023886","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170023886?lang=zh_cn&edition=fundamental","pubTime":"2025-11-19 16:02","pubTimestamp":1763539331,"startTime":"0","endTime":"0","summary":"澳大利亚收购委员会：Cosette在Salisbury的意图变化意味着对MAYNE的控制市场未能按一般方式推进","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","MYX.AU","BK7508"],"gpt_icon":0},{"id":"1134813682","title":"澳大利亚收购委员会临时命令限制Cosette在未经事先同意的情况下采取任何终止Sid的措施","url":"https://stock-news.laohu8.com/highlight/detail?id=1134813682","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134813682?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 12:51","pubTimestamp":1763095870,"startTime":"0","endTime":"0","summary":"澳大利亚收购委员会临时命令限制Cosette在未经事先同意的情况下采取任何终止Sid的措施。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7096","MYX.AU"],"gpt_icon":0},{"id":"1167970201","title":"澳大利亚收购委员会 - 在特定情况下，委员会认为维持现状所需的临时命令是必要的","url":"https://stock-news.laohu8.com/highlight/detail?id=1167970201","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167970201?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 12:50","pubTimestamp":1763095823,"startTime":"0","endTime":"0","summary":"澳大利亚收购委员会 - 在特定情况下，委员会认为维持现状所需的临时命令是必要的","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","BK7508","MYX.AU"],"gpt_icon":0},{"id":"1157529952","title":"澳大利亚收购委员会 - 临时命令修订MAYNE PHARMA GROUP LTD与Cosette Pharma之间的方案实施契约结束日期定义","url":"https://stock-news.laohu8.com/highlight/detail?id=1157529952","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157529952?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 12:50","pubTimestamp":1763095813,"startTime":"0","endTime":"0","summary":"澳大利亚收购委员会 - 临时命令修订MAYNE PHARMA GROUP LTD与Cosette Pharma之间的方案实施契约结束日期定义","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYX.AU","BK7508","BK7096"],"gpt_icon":0},{"id":"1175509821","title":"Mayne Pharma Group Ltd - 外国投资审查委员会将Firb批准的法定截止日期延长至11月17日","url":"https://stock-news.laohu8.com/highlight/detail?id=1175509821","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175509821?lang=zh_cn&edition=fundamental","pubTime":"2025-11-13 11:46","pubTimestamp":1763005569,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group Ltd - 外国投资审查委员会将Firb批准的法定截止日期延长至11月17日","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","BK7508","MYX.AU"],"gpt_icon":0},{"id":"1199687473","title":"Mayne Pharma - ASIC正式批准公司将2025年股东大会的召开时间从11月28日或之前延长至1月30日或之前","url":"https://stock-news.laohu8.com/highlight/detail?id=1199687473","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199687473?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 14:46","pubTimestamp":1762497972,"startTime":"0","endTime":"0","summary":"Mayne Pharma - ASIC正式批准公司将2025年股东大会的召开时间从11月28日或之前延长至1月30日或之前","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","BK7508","MYX.AU"],"gpt_icon":0},{"id":"1180672738","title":"澳大利亚收购委员会 - Mayne寻求最终命令，包括Cosette同意将 FIRB 的决定法定截止日期延长至12月1日","url":"https://stock-news.laohu8.com/highlight/detail?id=1180672738","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180672738?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 15:35","pubTimestamp":1762414512,"startTime":"0","endTime":"0","summary":"澳大利亚收购委员会 - Mayne寻求最终命令，包括Cosette同意将 FIRB 的决定法定截止日期延长至12月1日","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","MYX.AU","BK7096"],"gpt_icon":0},{"id":"1130202281","title":"澳大利亚收购委员会 - Mayne寻求临时命令，包括Cosette向委员会确认将与Firb会面","url":"https://stock-news.laohu8.com/highlight/detail?id=1130202281","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130202281?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 15:34","pubTimestamp":1762414452,"startTime":"0","endTime":"0","summary":"澳大利亚收购委员会 - Mayne寻求临时命令，包括Cosette向委员会确认将与Firb会面","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYX.AU","BK7508","BK7096"],"gpt_icon":0},{"id":"2579766456","title":"澳大利亚财政部长考虑阻止科赛特竞购后，梅因制药股价大跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2579766456","media":"路透中文","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579766456?lang=zh_cn&edition=fundamental","pubTime":"2025-10-31 17:18","pubTimestamp":1761902334,"startTime":"0","endTime":"0","summary":"更新 1-澳大利亚财政部长考虑阻止科赛特竞购后，梅因制药股价大跌财政部长称收购可能违背国家利益据媒体报导，珂赛特关闭梅恩阿德莱德工厂的计划可能导致200个工作岗位流失投资者警告称，该决定可能阻碍澳大利亚未来的并购交易重铸并通过Scott Murdoch路透10月31日 - 周五，梅恩制药MYX.AX的股价暴跌近三分之一，因为有消息称澳大利亚财政部长正在考虑阻止现在不情愿的收购方Cosette Pharmaceuticals对该公司提出的6.72亿澳元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251031:nL4T3WC0TC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYX.AU","BK7508","BK7096"],"gpt_icon":0},{"id":"1193649617","title":"梅因制药股价下跌至38.6%，因澳大利亚财政部长考虑阻止收购要约","url":"https://stock-news.laohu8.com/highlight/detail?id=1193649617","media":"美股速递","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193649617?lang=zh_cn&edition=fundamental","pubTime":"2025-10-31 07:25","pubTimestamp":1761866710,"startTime":"0","endTime":"0","summary":"梅因制药的股价下跌至38.6%，原因是澳大利亚财政部长考虑是否阻止该公司的收购要约。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYX.AU","BK7508","BK7096"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":22,"code":"91000000","status":"200"}]}}